 Stroke Volume
"Stroke Volume" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The amount of BLOOD pumped out of the HEART per beat, not to be confused with cardiac output (volume/time). It is calculated as the difference between the end-diastolic volume and the end-systolic volume.
| Descriptor ID |
D013318
|
| MeSH Number(s) |
E01.370.370.380.150.700 G09.330.380.124.882
|
| Concept/Terms |
Stroke Volume- Stroke Volume
- Stroke Volumes
- Volume, Stroke
- Volumes, Stroke
Ventricular End-Systolic Volume- Ventricular End-Systolic Volume
- End-Systolic Volume, Ventricular
- End-Systolic Volumes, Ventricular
- Ventricular End Systolic Volume
- Ventricular End-Systolic Volumes
- Volume, Ventricular End-Systolic
- Volumes, Ventricular End-Systolic
Ventricular Ejection Fraction- Ventricular Ejection Fraction
- Ejection Fraction, Ventricular
- Ejection Fractions, Ventricular
- Fraction, Ventricular Ejection
- Fractions, Ventricular Ejection
- Ventricular Ejection Fractions
Ventricular End-Diastolic Volume- Ventricular End-Diastolic Volume
- End-Diastolic Volume, Ventricular
- End-Diastolic Volumes, Ventricular
- Ventricular End Diastolic Volume
- Ventricular End-Diastolic Volumes
- Volume, Ventricular End-Diastolic
- Volumes, Ventricular End-Diastolic
|
Below are MeSH descriptors whose meaning is more general than "Stroke Volume".
Below are MeSH descriptors whose meaning is more specific than "Stroke Volume".
This graph shows the total number of publications written about "Stroke Volume" by people in this website by year, and whether "Stroke Volume" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 1 | 2 | | 1997 | 3 | 4 | 7 | | 1998 | 0 | 3 | 3 | | 1999 | 1 | 1 | 2 | | 2000 | 0 | 1 | 1 | | 2001 | 0 | 3 | 3 | | 2002 | 0 | 5 | 5 | | 2003 | 1 | 5 | 6 | | 2004 | 0 | 5 | 5 | | 2005 | 0 | 3 | 3 | | 2006 | 0 | 2 | 2 | | 2007 | 0 | 7 | 7 | | 2008 | 0 | 5 | 5 | | 2009 | 1 | 4 | 5 | | 2010 | 2 | 4 | 6 | | 2011 | 3 | 5 | 8 | | 2012 | 5 | 8 | 13 | | 2013 | 7 | 6 | 13 | | 2014 | 2 | 9 | 11 | | 2015 | 5 | 12 | 17 | | 2016 | 5 | 13 | 18 | | 2017 | 7 | 20 | 27 | | 2018 | 6 | 11 | 17 | | 2019 | 9 | 15 | 24 | | 2020 | 6 | 16 | 22 | | 2021 | 8 | 20 | 28 | | 2022 | 0 | 27 | 27 | | 2023 | 0 | 37 | 37 | | 2024 | 15 | 12 | 27 | | 2025 | 10 | 18 | 28 | | 2026 | 3 | 5 | 8 |
To return to the timeline, click here.
Below are the most recent publications written about "Stroke Volume" by people in Profiles.
-
Jacobs JA, Greene T, Vanneman ME, Kean J, Carter SJ, Shah KS, Pandey A, Derington CG, Zheutlin AR, Fang J, Stehlik J, Fonarow GC, Bress AP. Time to Quadruple Therapy After Initial Diagnosis of Heart Failure With Reduced Ejection Fraction. JAMA Cardiol. 2026 06 01; 11(6):506-514.
-
Dunlay SM, Colvin M, Cowger JA, Crespo Leiro MG, Desai AS, Greene SJ, Gustafsson F, Hall S, Ilonze OJ, Lala A, Lam CSP, Page RL, Lund LH, McDonagh TA, McIlvennan CK, Pinney SP, Truby LK, Yancy CW, Bozkurt B, Stevenson LW. Ambulatory Stage C2D Heart Failure Definitions and Current Therapeutic Approaches: JACC: Heart Failure Position Statement. JACC Heart Fail. 2026 Jun; 14(6):103101.
-
Andrade-Bucknor S, Rodriguez BPR, Ma C, Lyubarova R, Kondapalli L. Imaging in Cardio-Oncology: Role of Novel Echo Parameters in Breast Cancer and Gynecologic Malignancies. Curr Cardiol Rep. 2026 Apr 23; 28(1).
-
Martins EB, Madrini V, Ramos Souza PV, Tavares CAM, Albuquerque MT, Santo KE, Harrington JA, Canonico ME, El Rafei A, Bonaca MP, Guimaraes PO. ANSWER-HF: sacubitril-valsartan reduces NT-proBNP in heart failure due to Chagas cardiomyopathy despite no reverse remodeling. Heart Fail Rev. 2026 Mar 23; 31(1).
-
Leahy MG, Howden EJ, Lawley JS, Cornwell WK, MacNamara JP, Levine BD, Sarma S. The effect of sex on ventricular filling pressure during graded exercise in healthy young adults. J Appl Physiol (1985). 2026 04 01; 140(4):1099-1107.
-
Butler J, Fioretti F, McMullan CJ, Anstrom KJ, Barash I, Bonaca MP, Borentain M, Corda S, Teixeira PP, Ezekowitz JA, Gates D, Lam CSP, Lewis EF, Lindenfeld J, Mentz RJ, O'Connor CM, Ponikowski P, Reddy YNV, Rosano GMC, Saldarriaga C, Senni M, Udelson J, Urbinati A, Vlajnic V, Voors AA, Xing A, Patel MJ, Zannad F. Vericiguat and mortality in heart failure and reduced ejection fraction: the VICTOR trial. Eur Heart J. 2026 Feb 11; 47(6):683-697.
-
Harrington J, Pandey A. Heart failure with preserved ejection fraction: a systemic condition of comorbidities. Heart Fail Rev. 2026 Feb 03; 31(1):22.
-
de Alcantara Lima N, Rahman N, Afonso LC, Waldo SW, Don CW, Nathan A, Ramappa P. Clinical Outcomes and Haemodynamics: High Output Heart Failure Versus Heart Failure With Preserved Ejection Fraction. Heart Lung Circ. 2026 Mar; 35(3):356-365.
-
Chang HY, Liao CT, Heidenreich PA, Allen LA, Sung SH, Chen WJ, Wang TD, Li YH, Hsu CY, Wu YW, Huang N. Implementation of the Get With The Guidelines-Heart Failure Adherence to Science, Implementation in Asia (GWTG-HF A.S.I.A.) Program in Taiwan. J Am Heart Assoc. 2026 Jan 06; 15(1):e047097.
-
Kaski JP, Kantor PF, Nakano SJ, Olivotto I, Russell MW, Godown J, Chiu M, German P, Heitner SB, Jacoby DL, Kupfer S, Lutz J, Maharao N, Malik FI, Melloni C, Nieto Morales PF, Simkins T, Wei J, Ho CY. Efficacy and Safety of Aficamten in Children and Adolescents With Obstructive Hypertrophic Cardiomyopathy: Study Design and Rationale of CEDAR-HCM. Circ Heart Fail. 2026 Feb; 19(2):e013418.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|